1 Min Read
Aug 12 (Reuters) - Fennec Pharmaceuticals Inc:
* Fennec provides corporate update and announces second quarter 2016 results
* Qtrly loss per share $0.06 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.